Status:
UNKNOWN
PROSAIC-DS Study (PROState AI in Cancer - Decision Support)
Lead Sponsor:
Guy's and St Thomas' NHS Foundation Trust
Collaborating Sponsors:
King's College Hospital NHS Trust
King's College London
Conditions:
Prostate Cancer
Eligibility:
MALE
35+ years
Phase:
NA
Brief Summary
Around 375,000 cancers are diagnosed in the UK annually, with this figure expected to reach 500,000 by 2035. As the number of different cancer treatment options and our scientific understanding contin...
Detailed Description
I
Eligibility Criteria
Inclusion
- All patients referred to the GSTT and KCH Prostate MDT meetings where sufficient information is available for the MDT to make a treatment decision (approximately 40-50 per week) will be eligible for the study.
Exclusion
- If data available for patients is not adequate to make any treatment decisions they will be excluded. Non-consenting patients will be excluded.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1040 Patients enrolled
Trial Details
Trial ID
NCT05355727
Start Date
June 1 2022
End Date
December 1 2022
Last Update
May 2 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Guys and St Thomas Hospitals
London, United Kingdom, SE1 9RT
2
Kings College Hospital
London, United Kingdom, SE5 9RS